Literature DB >> 11325668

Cause of residual hypertension after adrenalectomy in patients with primary aldosteronism.

Y Horita1, T Inenaga, H Nakahama, H Ishibashi-Ueda, Y Kawano, S Nakamura, T Horio, N Okuda, M Ando, S Takishita.   

Abstract

The cause of residual hypertension after adrenalectomy for primary aldosteronism (PA) is unknown. The purpose of this study is to investigate the characteristic pathological kidney features associated with PA. Between 1977 and 1999 at our hospital, 26 patients with PA caused by a unilateral adrenal cortical adenoma (Conn's syndrome) underwent unilateral adrenalectomy with concurrent open-wedge renal biopsy. Patients were categorized into two groups: (1) those with normotension with diastolic blood pressure less than 90 mm Hg who were not administered antihypertensive drugs, and (2) those with residual hypertension with diastolic blood pressure of 90 mm Hg or greater who were administered medication for 6 months after surgery. Thirteen patients were cured of hypertension postoperatively, and 12 patients were administered antihypertensive medications. Glomerulosclerosis, renal arteriolosclerosis, and preoperative left ventricular mass (LVM) index were worse in the group with residual hypertension than in that with normotension (17.8% +/- 7.8% versus 9.6% +/- 3.8%; P = 0.01; 2.5 +/- 0.5 versus 1.6 +/- 0.4, Bader's grade; P = 0.005; and 165 +/- 31 versus 139 +/- 24 g/m(2); P = 0.02, respectively). Severity of tubulointerstitial injury, preoperative duration of hypertension, preoperative severity of proteinuria, plasma aldosterone level, and serum potassium concentration were not significantly different between the two groups. In conclusion, severity of glomerulosclerosis and arteriolosclerosis and LVM are related to blood pressure after adrenalectomy in patients with PA.

Entities:  

Mesh:

Year:  2001        PMID: 11325668     DOI: 10.1016/s0272-6386(05)80002-2

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  10 in total

Review 1.  Primary aldosteronism: from bench to bedside.

Authors:  Norlela Sukor
Journal:  Endocrine       Date:  2011-11-01       Impact factor: 3.633

2.  The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old.

Authors:  Chin-Chi Kuo; Poojitha Balakrishnan; Yenh-Chen Hsein; Vin-Cent Wu; Shih-Chieh Jeff Chueh; Yung-Ming Chen; Kwan-Dun Wu; Ming-Jiuh Wang
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2014-07-16       Impact factor: 1.636

Review 3.  The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD.

Authors:  Yuka Sato; Daniel I Feig; Austin G Stack; Duk-Hee Kang; Miguel A Lanaspa; A Ahsan Ejaz; L Gabriela Sánchez-Lozada; Masanari Kuwabara; Claudio Borghi; Richard J Johnson
Journal:  Nat Rev Nephrol       Date:  2019-07-11       Impact factor: 28.314

4.  Adrenal venous sampling for primary aldosteronism and clinical outcomes after unilateral adrenalectomy: a single-center experience.

Authors:  Miho Murashima; Scott O Trerotola; Douglas L Fraker; Dale Han; Raymond R Townsend; Debbie L Cohen
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-06       Impact factor: 3.738

5.  Primary aldosteronism: from case detection to histopathology with up to 6 years of follow-up.

Authors:  Gudbjörg Jonsdottir; Jon Gudmundsson; Gudjon Birgisson; Helga Agusta Sigurjonsdottir
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-11-23       Impact factor: 3.738

6.  Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population.

Authors:  Vin-Cent Wu; Kuo-How Huang; Kang-Yung Peng; Yao-Chou Tsai; Che-Hsiung Wu; Shuo-Meng Wang; Shao-Yu Yang; Lian-Yu Lin; Chin-Chen Chang; Yen-Hung Lin; Shuei-Liong Lin; Tzong-Shinn Chu; Kwan-Dun Wu
Journal:  Sci Rep       Date:  2015-06-12       Impact factor: 4.379

7.  Arterial stiffness and blood pressure improvement in aldosterone-producing adenoma harboring KCNJ5 mutations after adrenalectomy.

Authors:  Chia-Hui Chang; Ya-Hui Hu; Yao-Chou Tsai; Che-Hsiung Wu; Shuo-Meng Wang; Lian-Yu Lin; Yen-Hung Lin; Fumitoshi Satoh; Kwan-Dun Wu; Vin-Cent Wu
Journal:  Oncotarget       Date:  2017-05-02

8.  Unmasked renal impairment and prolonged hyperkalemia after unilateral adrenalectomy for primary aldosteronism coexisting with primary hyperparathyroidism: report of a case.

Authors:  Yatsuka Hibi; Nobuki Hayakawa; Midori Hasegawa; Kimio Ogawa; Yoshimi Shimizu; Masahiro Shibata; Chikara Kagawa; Yutaka Mizuno; Yukio Yuzawa; Mitsuyasu Itoh; Katsumi Iwase
Journal:  Surg Today       Date:  2013-12-17       Impact factor: 2.549

9.  Unmasked chronic renal function deterioration after unilateral adrenalectomy in patients with primary aldosteronism.

Authors:  Su Min Park; Woo Jin Jung; Jong Man Park; Harin Rhee; Il Young Kim; Eun Young Seong; Dong Won Lee; Soo Bong Lee; Ihm Soo Kwak; Nari Shin; Sang Heon Song
Journal:  Kidney Res Clin Pract       Date:  2016-05-20

Review 10.  Hypertension outcomes of adrenalectomy in patients with primary aldosteronism: a systematic review and meta-analysis.

Authors:  Yu Zhou; Meilian Zhang; Sujie Ke; Libin Liu
Journal:  BMC Endocr Disord       Date:  2017-10-03       Impact factor: 2.763

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.